Experienced in Blepharitis

Aldina P. Barral

Sao Paulo, SP, BR 
Experienced in Blepharitis
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Aldina Barral practices in Sao Paulo, Brazil. Barral is rated as an Experienced expert by MediFind in the treatment of Blepharitis. Their top areas of expertise are Leishmaniasis, Togaviridae Disease, Chikungunya, and Pneumonia.

Their clinical research consists of co-authoring 105 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Blepharitis.

Locations

Sao Paulo, SP, Brazil
Other Locations
Fundação De Medicina Tropical Dr. Heitor Vieira Dourado, Boa Vista, Sao Jose Do Rio Preto, SP, Brazil
Salvador, BA, Brazil
Santa Cruz, BA, Brazil
Goncalo, BA, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Immunogenicity of the Dengue 1, 2, 3, 4 (Attenuated) Vaccine From Instituto Butantan
Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Immunogenicity of the Dengue 1, 2, 3, 4 (Attenuated) Vaccine From Instituto Butantan
Enrollment Status: Active_not_recruiting
Publish Date: February 15, 2024
Intervention Type: Other, Biological
Study Drug: Dengue 1,2,3,4 (Attenuated) Vaccine
Study Phase: Phase 3

104 Total Publications

High glucose heightens vulnerability to Leishmania braziliensis infection in human macrophages by hampering the production of reactive oxygen species through TLR2 and TLR4.
High glucose heightens vulnerability to Leishmania braziliensis infection in human macrophages by hampering the production of reactive oxygen species through TLR2 and TLR4.
Journal: Emerging microbes & infections
Published: March 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Barral's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile